If J&J's phase 3 trial report very strong efficacy, it will be the single-shot vaccine that can be stored and transported at refrigerator temperatures unlike Pfizer and Moderna.
More than 90% of participants made immune proteins within 29 days after receiving the shot & all participants formed the antibodies within 57 days, according to the report.
The deal comes after a study showed Johnson & Johnson’s candidate vaccine generated strong antibody response in primates and provided protection with a single dose.
J&J announced in June that it had accelerated vaccine trials with ambitions of launching human studies in mid-July. The company will dose its first patients on 22 July in Belgium.
The US-govt-sponsored study may help Johnson & Johnson's fight against 17,000 lawsuits contending that talc-based personal hygiene products cause ovarian cancer in women.
BJP’s fate in the second phase of 2024 Lok Sabha election will be decided in Karnataka, Rajasthan, and Maharashtra, where it performed very well in 2019 but faces a stiff competition now.
The private lender's shares tumbled to be top Nifty 50 loser after India's central bank barred it from taking on new customers through online and mobile banking channels.
Another addition to military cooperation has been the Strategic Space Dialogue, inaugurated in Paris in 2023. Last month, India participated as an observer to France’s AsterX.
COMMENTS